Structures by: ManojKumar K. E.
Total: 10
<i>tert</i>-Butyl 4-{5-[3-(trifluoromethoxy)phenyl]-1,2,4-oxadiazol-3-yl}piperazine-1-carboxylate
C18H21F3N4O4
Acta Crystallographica Section E (2013) 69, 5 o761
a=5.773(2)Å b=11.168(5)Å c=15.991(7)Å
α=96.092(16)° β=100.316(14)° γ=91.333(14)°
Methyl 4-(trifluoromethyl)-1<i>H</i>-pyrrole-3-carboxylate
C7H6F3NO2
Acta Crystallographica Section E (2013) 69, 10 o1566
a=16.643(2)Å b=7.1118(10)Å c=6.9618(11)Å
α=90.00° β=98.903(7)° γ=90.00°
4-Methyl-2,6-bis(pyrrolidin-1-yl)pyrimidine
C13H20N4
Acta Crystallographica Section E (2012) 68, 12 o3440
a=6.344(3)Å b=8.766(4)Å c=12.056(6)Å
α=79.10(3)° β=86.05(3)° γ=85.72(3)°
1-(2-Amino-6-methylpyrimidin-4-yl)-<i>N</i>,<i>N</i>-dimethylpiperidin- 4-aminium chloride
C12H22N5,Cl
Acta Crystallographica Section E (2012) 68, 12 o3371
a=24.7908(12)Å b=8.2419(4)Å c=13.8764(6)Å
α=90.00° β=91.968(2)° γ=90.00°
(E)-3-chloro-N'-hydroxybenzamidine
C7H7ClN2O
Acta Crystallographica Section E (2012) 68, 12 o3402
a=5.0018(17)Å b=10.984(4)Å c=14.407(6)Å
α=74.000(12)° β=89.952(12)° γ=89.877(11)°
(2,3-Difluorophenyl)(4-tosylpiperazin-1-yl)methanone
C18H18F2N2O3S
Acta Crystallographica Section E (2013) 69, 2 o185
a=17.0456(4)Å b=7.60260(10)Å c=15.5113(3)Å
α=90.00° β=113.5130(10)° γ=90.00°
1-Tosyl-4-[2-(trifluoromethyl)benzyl]piperazine
C19H21F3N2O2S
Acta Crystallographica Section E (2013) 69, 2 o239
a=9.5044(3)Å b=9.8389(3)Å c=12.1473(4)Å
α=72.0360(10)° β=77.0240(10)° γ=62.3840(10)°
4-Methyl-6-(piperidin-1-yl)pyrimidin-2-amine
C10H16N4
Acta Crystallographica Section E (2013) 69, 2 o197
a=13.9605(4)Å b=8.7564(3)Å c=17.7055(6)Å
α=90.00° β=104.381(2)° γ=90.00°
5-Fluoroanthranilic acid
C7H6FNO2
Acta Crystallographica Section E (2013) 69, 3 o387
a=4.9346(2)Å b=11.7542(6)Å c=11.9727(5)Å
α=90.00° β=96.782(3)° γ=90.00°
1-(2,4-Dichlorobenzyl)-4-[(4-methylphenyl)sulfonyl]piperazine
C18H20Cl2N2O2S
Acta Crystallographica Section E (2013) 69, 5 o782
a=28.2896(5)Å b=28.2896(5)Å c=13.3041(3)Å
α=90.00° β=90.00° γ=120.00°